Having determined the palmitoylation motif of APLNR, we made a short substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This aggressive peptide, which targets the APLNR palmitoylation web-site in combination with morphine, can inhibit the development of NCP, which includes pain incidence, microglial activation, and inflammatory issue https://fridau814ocn5.sasugawiki.com/user